Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$35.55 - $43.57 $544,128 - $666,882
15,306 Added 118.77%
28,193 $1.22 Million
Q3 2023

Nov 16, 2023

BUY
$39.13 - $47.24 $14,908 - $17,998
381 Added 3.05%
12,887 $521,000
Q2 2023

Jul 21, 2023

BUY
$43.93 - $46.76 $549,388 - $584,780
12,506 New
12,506 $563,000
Q4 2022

Feb 10, 2023

BUY
$41.91 - $50.48 $228,619 - $275,368
5,455 New
5,455 $272,000
Q1 2022

May 16, 2022

SELL
$42.23 - $54.3 $164,612 - $211,661
-3,898 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$50.62 - $56.47 $197,316 - $220,120
3,898 New
3,898 $217,000
Q2 2021

Aug 04, 2021

SELL
$46.28 - $52.75 $593,957 - $676,993
-12,834 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$46.25 - $56.02 $111,508 - $135,064
-2,411 Reduced 15.82%
12,834 $625,000
Q4 2020

Jan 29, 2021

BUY
$46.09 - $54.74 $702,642 - $834,511
15,245 New
15,245 $806,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.